Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
View ORCID ProfileSarah M Lofgren, View ORCID ProfileMelanie R Nicol, Ananta S Bangdiwala, View ORCID ProfileKatelyn A Pastick, View ORCID ProfileElizabeth C Okafor, View ORCID ProfileCaleb P Skipper, View ORCID ProfileMatthew F Pullen, View ORCID ProfileNicole W Engen, View ORCID ProfileMahsa Abassi, Darlisha A Williams, View ORCID ProfileAlanna A Nascene, View ORCID ProfileMargaret L Axelrod, Sylvain A Lother, View ORCID ProfileLauren J MacKenzie, View ORCID ProfileGlen Drobot, Nicole Marten, View ORCID ProfileMatthew P Cheng, Ryan Zarychanski, View ORCID ProfileIlan S Schwartz, Michael Silverman, View ORCID ProfileZain Chagla, Lauren E Kelly, View ORCID ProfileEmily G McDonald, View ORCID ProfileTodd C Lee, View ORCID ProfileKathy H Hullsiek, View ORCID ProfileDavid R. Boulware, View ORCID ProfileRadha Rajasingham
doi: https://doi.org/10.1101/2020.07.16.20155531
Sarah M Lofgren
1University of Minnesota, Minneapolis, Minnesota
Melanie R Nicol
1University of Minnesota, Minneapolis, Minnesota
Ananta S Bangdiwala
1University of Minnesota, Minneapolis, Minnesota
Katelyn A Pastick
1University of Minnesota, Minneapolis, Minnesota
Elizabeth C Okafor
1University of Minnesota, Minneapolis, Minnesota
Caleb P Skipper
1University of Minnesota, Minneapolis, Minnesota
Matthew F Pullen
1University of Minnesota, Minneapolis, Minnesota
Nicole W Engen
1University of Minnesota, Minneapolis, Minnesota
Mahsa Abassi
1University of Minnesota, Minneapolis, Minnesota
Darlisha A Williams
1University of Minnesota, Minneapolis, Minnesota
Alanna A Nascene
1University of Minnesota, Minneapolis, Minnesota
Margaret L Axelrod
2Vanderbilt University Medical Center, Nashville, Tennessee
BScSylvain A Lother
3Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba
Lauren J MacKenzie
3Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba
Glen Drobot
3Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba
Nicole Marten
4George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba
Matthew P Cheng
6Research Institute of the McGill University Health Centre, Montreal, Quebec
7Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec
Ryan Zarychanski
3Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba
4George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba
Ilan S Schwartz
5Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta
Michael Silverman
8Lawson Research Institute, St. Joseph’s Healthcare Center, London, Ontario
Zain Chagla
9McMaster University, Hamilton, Ontario
Lauren E Kelly
4George & Fay Yee Centre for Healthcare Innovation, Winnipeg, Manitoba
Emily G McDonald
6Research Institute of the McGill University Health Centre, Montreal, Quebec
7Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec
Todd C Lee
6Research Institute of the McGill University Health Centre, Montreal, Quebec
7Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal, Quebec
Kathy H Hullsiek
1University of Minnesota, Minneapolis, Minnesota
David R. Boulware
1University of Minnesota, Minneapolis, Minnesota
Radha Rajasingham
1University of Minnesota, Minneapolis, Minnesota
Article usage
Posted August 18, 2020.
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, Katelyn A Pastick, Elizabeth C Okafor, Caleb P Skipper, Matthew F Pullen, Nicole W Engen, Mahsa Abassi, Darlisha A Williams, Alanna A Nascene, Margaret L Axelrod, Sylvain A Lother, Lauren J MacKenzie, Glen Drobot, Nicole Marten, Matthew P Cheng, Ryan Zarychanski, Ilan S Schwartz, Michael Silverman, Zain Chagla, Lauren E Kelly, Emily G McDonald, Todd C Lee, Kathy H Hullsiek, David R. Boulware, Radha Rajasingham
medRxiv 2020.07.16.20155531; doi: https://doi.org/10.1101/2020.07.16.20155531
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, Katelyn A Pastick, Elizabeth C Okafor, Caleb P Skipper, Matthew F Pullen, Nicole W Engen, Mahsa Abassi, Darlisha A Williams, Alanna A Nascene, Margaret L Axelrod, Sylvain A Lother, Lauren J MacKenzie, Glen Drobot, Nicole Marten, Matthew P Cheng, Ryan Zarychanski, Ilan S Schwartz, Michael Silverman, Zain Chagla, Lauren E Kelly, Emily G McDonald, Todd C Lee, Kathy H Hullsiek, David R. Boulware, Radha Rajasingham
medRxiv 2020.07.16.20155531; doi: https://doi.org/10.1101/2020.07.16.20155531
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2763)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4275)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2763)
- Health Policy (1023)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (455)
- Neurology (4058)
- Nursing (218)
- Nutrition (601)
- Oncology (2141)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (471)
- Public and Global Health (6663)
- Radiology and Imaging (1455)
- Respiratory Medicine (886)
- Rheumatology (423)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (193)
- Urology (171)